Rating History for Ligand Pharma (LGND) by Citi

More Stocks Rated by Citi | Latest Ratings for LGND
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/21/2026 Yigal Nochomovitz New Coverage Buy
(N/A)		 387.00
(N/A)		 293.99
(284.27)		 -3.31% Details